Report

Help us improve this tool

Warfarin Dosing Calculator

Calculate warfarin dosage adjustments, single booster or omitted doses, and monitoring intervals based on patient INR and target INR range.

O M T

What Is the Warfarin Dosing Calculator?

The Warfarin Dosing Calculator is a clinical decision support tool designed to assist healthcare professionals and anticoagulation management providers in adjusting maintenance warfarin (Coumadin) doses based on measured International Normalized Ratio (INR) levels. Warfarin is a narrow therapeutic index oral anticoagulant used to prevent and treat thromboembolic events such as deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic stroke in patients with atrial fibrillation or prosthetic heart valves.

Because warfarin's anticoagulant response is affected by genetics, diet, and concurrent medications, regular monitoring of the INR is vital. You can convert laboratory values using our INR Calculator or evaluate baseline thrombotic risks with the VTE Risk Score in Pregnancy Calculator.

Target INR Ranges and Clinical Indications

Clinical guidelines from the American College of Chest Physicians (ACCP) and the American Society of Hematology (ASH) define two standard therapeutic target ranges:

  • Target INR 2.0 to 3.0 (Midpoint 2.5): Recommended for the vast majority of indications, including non-valvular atrial fibrillation, treatment and secondary prevention of DVT and PE, and bioprosthetic heart valves.
  • Target INR 2.5 to 3.5 (Midpoint 3.0): Indicated for patients with mechanical mitral valves or high-risk mechanical aortic valves.

Evidence-Based Dosage Adjustment Protocols

Warfarin adjustments are typically calculated based on percentage changes to the total weekly dose (TWD).

Current INR (Target 2.0 - 3.0) Weekly Dose Adjustment Booster or Hold Action Next Recheck
< 1.5 Increase by 5% to 20% Single booster dose (1.5 - 2× daily dose) 3 to 7 days
1.5 - 1.7 Increase by 5% to 15% Single booster dose (1.5 - 2× daily dose) 3 to 7 days
1.8 - 1.9 Increase by 5% to 10% (or no change if prior 2 in range) Optional booster dose 3 to 7 days (7-14 if stable)
2.0 - 3.0 No change (Maintain dose) None 2 to 4 weeks
3.1 - 3.4 Decrease by 5% to 10% (or no change if prior 2 in range) Consider omitting 1 dose 3 to 7 days
3.5 - 3.9 Decrease by 5% to 15% Omit 1 dose, then resume at reduced dose 1 to 3 days
> 4.0 Decrease by 10% to 20% Hold 1-2 doses; evaluate for bleeding / oral vitamin K 24 hours (1 day)

How to Calculate Total Weekly Dose (TWD) Adjustments

To adjust a patient's regimen smoothly, clinicians often adjust the weekly total and distribute tablet strengths across the 7 days of the week:

  1. Calculate current total weekly dose: Current TWD = Daily Dose × 7.
  2. Calculate the new total weekly target: New TWD = Current TWD × (1 ± Adjustment Percentage).
  3. Divide the new TWD evenly across days or alternate tablet strengths (e.g. 5 mg on 5 days, 2.5 mg on 2 days).

Frequently Asked Questions

What factors cause unexpected INR fluctuations?

Common causes include missed or extra doses, changes in dietary vitamin K intake (green leafy vegetables), alcohol consumption, acute illnesses (fever, diarrhea, vomiting), and drug interactions with antibiotics, antifungal agents, or NSAIDs.

When should a single booster dose be considered?

A single booster dose of 1.5 to 2 times the normal daily maintenance dose is often considered when the INR is subtherapeutic (< 1.8 for standard target) without active bleeding, particularly when rapid return to therapeutic range is desired.

How often should INR be tested once stable?

Once a patient has consistent therapeutic INR readings on a stable dose, monitoring intervals can be extended to every 2 to 4 weeks (and up to 12 weeks in selected highly stable individuals per CHEST guidelines).

What should be done if INR is greater than 4.5 without bleeding?

Guidelines generally recommend withholding 1 to 2 doses of warfarin, monitoring INR closely, and resuming at an adjusted lower dose once INR is in range. Routine vitamin K is not recommended for INR 4.5 to 10 unless there is significant bleeding risk.